Switzerland, January 30: Vilin Bio Med Limited, a premier Indian pharmaceutical manufacturer, has marked a historic presence at the 56th Annual Meeting of the World Economic Forum (WEF) in Davos. Led by Managing Director Dr. Madhu Sudhan Reddy Yadamakanti, the company has finalized transformative agreements with the Governments of Maharashtra and Kerala, alongside initiating high-level expansion talks with Qatar.
Building India’s Premier Pharma Hub in Maharashtra
In a monumental development for the Indian pharmaceutical landscape, Skaah Group Ag, Switzerland—through its SPV Skaah Pharma Ag—signed a Memorandum of Understanding (MoU) with the Government of Maharashtra to establish an Integrated Pharma City in Nashik.
Vilin Bio Med Limited holds a major stake in the SPV and will serve as the Primary Implementation Partner for this mega-project.
Key Project Details:
* Investment: A ₹2,100 Crore Foreign Direct Investment (FDI) commitment.
* Economic Impact: Expected to generate direct employment for 4,850 people.
* Timeline: Operations are projected to commence by 2029.
The MoU was signed by Dr. Madhu Sudhan Reddy Yadamakanti and Dr. P Anbalagan (IAS), Principal Secretary (Industries), in the distinguished presence of Hon’ble Chief Minister Shri Devendra Fadnavis and Hon’ble Minister for Industries Shri Uday Samant.
Vilin Bio Med Limited signed an Expression of Interest (EoI) with the Department of Industries & Commerce, Government of Kerala. This agreement outlines a ₹100 Crore investment to establish a state-of-the-art Medical Devices Manufacturing facility.
The project was finalized at the Kerala Pavilion with Shri P. Rajeeve, Hon’ble Minister for Industries, Law, and Coir.
Furthering its global footprint, the Vilin Bio Med leadership engaged in pivotal discussions at the Invest Qatar Pavilion. These talks focused on potential collaborations in pharmaceutical research and manufacturing opportunities within Qatar’s life sciences ecosystem, positioning Vilin Bio Med as a bridge between Swiss technology and Middle Eastern investment.
“Reason to sign these global agreements in Davos, my vision has always been to drive impactful growth,” said Dr. Madhu Sudhan Reddy Yadamakanti. “This success is a combined hard work of all our team and investors. We are not just building facilities; we are building a global healthcare ecosystem.”
